© 2010

Signaling Pathways in Liver Diseases

  • Jean-Francois Dufour
  • Pierre-Alain Clavien

Table of contents

  1. Front Matter
    Pages i-xii
  2. The Cell Types and the Matrix

    1. Front Matter
      Pages 2-2
    2. G. Ramadori, Pierluigi Ramadori
      Pages 3-24
    3. M. Fatima Leite, Viviane A. Andrade, Michael H. Nathanson
      Pages 25-39
    4. Fabio Marra, Sara Galastri, Sara Aleffi, Massimo Pinzani
      Pages 41-68
    5. Christian J. Steib, Alexander L. Gerbes
      Pages 69-78
    6. Robert C. Huebert, Vijay H. Shah
      Pages 79-91
    7. Scott L. Friedman
      Pages 93-104
    8. Mickael Lesurtel, Pierre-Alain Clavien
      Pages 105-116
    9. Ricky H. Bhogal, Simon C. Afford
      Pages 117-146
  3. The Pathways

    1. Front Matter
      Pages 148-148
    2. Gyongyi Szabo, Pranoti Mandrekar
      Pages 149-159
    3. Jörn M. Schattenberg, Mark J. Czaja
      Pages 161-177
    4. Maria Eugenia Guicciardi, Gregory J. Gores
      Pages 179-188
    5. Markus H. Heim
      Pages 189-200
    6. Tom Luedde, Christian Trautwein
      Pages 201-214
    7. R. Schwabe
      Pages 215-227
    8. Miran Kim, Jack R. Wands
      Pages 229-241
    9. Elena Zhuravleva, Oliver Tschopp, Brian A. Hemmings
      Pages 243-259
    10. Hala E. Thomas, Sara C. Kozma
      Pages 261-273

About this book


Signaling Pathways in Liver Diseases, 2nd edition focuses on signaling pathways which are particularly important in liver diseases. Recent progress brought hepatology to new frontiers. The increasing frequency of surgery on steatotic and cirrhotic liver obliges liver surgeons and hepatologists to understand the molecular mechanisms at play in these situations and how they can be influenced. Better comprehension of the cellular mechanisms participating in liver regeneration, hepato-cellular apoptosis and ischemia/reperfusion inquiry is mirrored by a dramatic increase in complexity. The number and scope of publications is intimidating and difficult for busy individuals to extract a coherent framework. This book will serve as a source of information facilitating the reading of the literature and the planning of trials. Translational medicine implies knowledge of the molecular targets for novel therapeutic strategies. It will furthermore stimulate more research and lead to better exchange between the laboratory, the clinical ward and the operation room.




Signaling Pathways Surgery Targeted Therapy apoptosis cancer hepatitis hepatobiliary diseases hepatology interferon liver liver disease molecular medicine physiology

Editors and affiliations

  • Jean-Francois Dufour
    • 1
  • Pierre-Alain Clavien
    • 2
  1. 1.InselspitalUniversität BernBernSwitzerland
  2. 2.Klinik für Viszeral- undUniversitätsspital ZürichZürichSwitzerland

Bibliographic information

Industry Sectors
Health & Hospitals
Surgery & Anesthesiology